| |
|
|
|
|
Cubist Pharmaceuticals, Inc.(CBST)
|
|
|
|
|
|
|
|
|
| 123Jump Rating: |
|
Underwriters: |
UBS Securities
|
| |
|
|
Hambrecht & Quist
|
| Status: |
|
|
Pacific Growth Equities, Inc.
|
| |
| Address: |
24 Emily Street
|
FiledDate: |
|
| |
|
|
|
| |
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
(617) 576 -1999 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
2,000,000 |
| |
|
|
|
| Websites: |
|
Shares Outstanding (Millions): |
8,373,023 |
| |
|
|
|
| Management: |
Scott M. Rocklage, Ph.D., Pres./CEO
|
IPO Date: |
|
| |
John K. Clarke, Chairman
|
|
|
| |
Thomas A. Shea, Treasurer
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
|
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
57 PT |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
|
S-1 Forms: |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 1992
|
0.00 |
0.00 |
0.00 |
0.00 |
-35 |
0.00 |
| 1993
|
0.00 |
1716 |
-1716 |
0.00 |
-1688 |
0.00 |
| 1994
|
0.00 |
4758 |
-4758 |
0.00 |
-4813 |
0.00 |
| 1995
|
1271 |
6674 |
-5403 |
0.00 |
-5396 |
-3.85 |
| 1996
|
4985 |
8860 |
-3875 |
0.00 |
-3799 |
-2.23 |
|
|
|
|
|
|
|
| |
|
| |
|
|
